Spending on glucagon-like peptide-1 receptor agonists (GLP-1 RAs) increased from 2018 to 2023, with the largest growth rates from 2022 to 2023. Although spending for certain GLP-1 RAs increased ...
Liraglutide is a peptide that has gained significant attention in scientific research due to its structural similarity to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback